Education
About Us
Working with TipRanks
Follow Us
Verici Dx Plc (GB:VRCI)
:VRCI
VRCI Stock Chart & Stats
Day’s Range― - ―
52-Week Range2.00p - 9.50p
Previous CloseN/A
Volume9.63K
Average Volume (3M)947.16K
Market Cap
£6.06M
Enterprise Value8.72M
Total Cash (Recent Filing)$2.65M
Total Debt (Recent Filing)$540.00K
Price to Earnings (P/E)―
Beta1.67
Next Earnings
Apr 09, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding242,541,470
10 Day Avg. Volume1,736,653
30 Day Avg. Volume947,159
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.72
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.44
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit8.61
Enterprise Value/Ebitda-1.16
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Verici Dx Plc News
PremiumCompany Announcements
Verici Dx Plc Experiences Shift in Major Shareholding
PremiumCompany Announcements
Verici Dx Foresees TutiviaTM Revenue Shift to FY25
PremiumCompany Announcements
Verici Dx Launches Groundbreaking Transplant Risk Assay
PremiumCompany Announcements
Verici Dx Plc Reports Revenue Growth and Strategic ProgressPremiumCompany Announcements
Verici Dx Plc to Unveil Mid-Year Results and Updates
PremiumCompany Announcements
Verici Dx Achieves Key Collaboration MilestonePremiumCompany Announcements
Verici Dx Shareholders Approve AGM Resolutions
PremiumCompany Announcements
Verici Dx Completes Key Sample Transfer---
Options Prices
Currently, No data available
---
Ownership Overview
0.67%
Insiders
0.02%
Mutual Funds
― Other Institutional Investors
99.98% Public Companies and
Individual Investors
VRCI FAQ
What was Verici Dx Plc’s price range in the past 12 months?
Verici Dx Plc lowest share price was 2.00p and its highest was 9.50p in the past 12 months.
What is Verici Dx Plc’s market cap?
Verici Dx Plc’s market cap is £6.06M.
When is Verici Dx Plc’s upcoming earnings report date?
Verici Dx Plc’s upcoming earnings report date is Apr 09, 2025 which is in 12 days.
How were Verici Dx Plc’s earnings last quarter?
Verici Dx Plc released its earnings results on Jul 15, 2024. The company reported -0.005p earnings per share for the quarter, missing the consensus estimate of N/A by -0.005p.
Is Verici Dx Plc overvalued?
According to Wall Street analysts Verici Dx Plc’s price is currently Overvalued.
Does Verici Dx Plc pay dividends?
Verici Dx Plc does not currently pay dividends.
What is Verici Dx Plc’s EPS estimate?
Verici Dx Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Verici Dx Plc have?
Verici Dx Plc has 242,541,470 shares outstanding.
What happened to Verici Dx Plc’s price movement after its last earnings report?
Verici Dx Plc reported an EPS of -0.005p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.385%.
Which hedge fund is a major shareholder of Verici Dx Plc?
Currently, no hedge funds are holding shares in GB:VRCI
---
Company Description
Verici Dx Plc
Verici Dx plc, an immuno-diagnostics development company, focuses on the kidney transplantation market. The company develops prognostic and diagnostic tests for kidney transplant patients. Its in-development tests include Clarava, a pre-transplant prognosis test for the risk of early acute rejection; Tuteva, a post-transplant test that focuses on acute cellular rejection; and Protega, a liquid biopsy that aims to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Penarth, the United Kingdom.
---
Technical Analysis
---